<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Qi L</submitter><funding>China Scholarship Council</funding><funding>NCCIH NIH HHS</funding><funding>NHLBI NIH HHS</funding><funding>National Institute of Health</funding><funding>American Diabetes Association</funding><funding>NIGMS NIH HHS</funding><pagination>59-73</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7483359</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>145</volume><pubmed_abstract>Deubiquitinating enzymes (DUBs) appear to be a new class of regulators of cardiac homeostasis and disease. However, DUB-mediated signaling in the heart is not well understood. Herein we report a novel mechanism by which cylindromatosis (CYLD), a DUB mediates cardiac pathological remodeling and dysfunction. Cardiomyocyte-restricted (CR) overexpression of CYLD (CR-CYLD) did not cause gross health issues and hardly affected cardiac function up to age of one year in both female and male mice at physiological conditions. However, CR-CYLD overexpression exacerbated pressure overload (PO)-induced cardiac dysfunction associated with suppressed cardiac hypertrophy and increased myocardial apoptosis in mice independent of the gender. At the molecular level, CR-CYLD overexpression enhanced PO-induced</pubmed_abstract><journal>Journal of molecular and cellular cardiology</journal><pubmed_title>CYLD exaggerates pressure overload-induced cardiomyopathy via suppressing autolysosome efflux in cardiomyocytes.</pubmed_title><pmcid>PMC7483359</pmcid><funding_grant_id>201506220204</funding_grant_id><funding_grant_id>R01 HL085629</funding_grant_id><funding_grant_id>1–16-IBS-059</funding_grant_id><funding_grant_id>P20 GM103641</funding_grant_id><funding_grant_id>R01 HL072166</funding_grant_id><funding_grant_id>P01 AT003961</funding_grant_id><funding_grant_id>R01 HL131667</funding_grant_id><pubmed_authors>Qi L</pubmed_authors><pubmed_authors>Zang H</pubmed_authors><pubmed_authors>Nagarkatti M</pubmed_authors><pubmed_authors>Liu Q</pubmed_authors><pubmed_authors>Wang X</pubmed_authors><pubmed_authors>Wu W</pubmed_authors><pubmed_authors>Nagarkatti P</pubmed_authors><pubmed_authors>Robbins J</pubmed_authors><pubmed_authors>Cui T</pubmed_authors></additional><is_claimable>false</is_claimable><name>CYLD exaggerates pressure overload-induced cardiomyopathy via suppressing autolysosome efflux in cardiomyocytes.</name><description>Deubiquitinating enzymes (DUBs) appear to be a new class of regulators of cardiac homeostasis and disease. However, DUB-mediated signaling in the heart is not well understood. Herein we report a novel mechanism by which cylindromatosis (CYLD), a DUB mediates cardiac pathological remodeling and dysfunction. Cardiomyocyte-restricted (CR) overexpression of CYLD (CR-CYLD) did not cause gross health issues and hardly affected cardiac function up to age of one year in both female and male mice at physiological conditions. However, CR-CYLD overexpression exacerbated pressure overload (PO)-induced cardiac dysfunction associated with suppressed cardiac hypertrophy and increased myocardial apoptosis in mice independent of the gender. At the molecular level, CR-CYLD overexpression enhanced PO-induced</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020 Aug</publication><modification>2026-05-07T15:15:34.208Z</modification><creation>2022-02-11T00:44:53.787Z</creation></dates><accession>S-EPMC7483359</accession><cross_references><pubmed>32553594</pubmed><doi>10.1016/j.yjmcc.2020.06.004</doi></cross_references></HashMap>